Collaboration for infectious disease diagnostics
Date: 17 October, 2013
Technology transfer organization and assay development company form agreement.
MRC Technology and Renishaw Diagnostics Ltd (RDL) recently announced a new partnership for research and development of clinical diagnostic assays for infectious disease. The collaboration will utilize RDL’s multiplex screening technology (the RenDx® assay system) and experience in assay development, alongside MRC Technology’s expertise in developing early-stage research for clinical applications.
Rupert Jones, RDL’s General Manager commented, “RDL is delighted to be working with MRC Technology as a leader in translating basic research into commercial opportunities. MRC Technology’s expertise and experience will allow us to accelerate development of our assay portfolio, enhancing the capabilities of the RenDx platform and providing end users with additional value and flexibility.”
Mike Dalrymple, MRC Technology added, “MRC Technology will build a capability in early-stage translation of diagnostic opportunities from academia at our laboratory facilities in Edinburgh. We are delighted to be working with RDL to identify opportunities that will take advantage of RDL’s platform and capabilities. Key to success will be ensuring information exchange between RDL and MRC Technology scientists, thus opening up the potential for future research collaboration.”
